Aarti Drugs Ltd Share Price
(AARTIDRUGS)
₹340.3
as on 04:01PM, 28 Mar 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -1.29 % |
3 Month Return | -26.19 % |
1 Year Return | -25.6 % |
Market Stats | |
Previous Close | ₹353.10 |
Open | ₹353.00 |
Volume | 2.65L |
Upper Circuit | ₹423.70 |
Lower Circuit | ₹282.50 |
Market Cap | ₹3,128.55Cr |
P/E Ratio
20.43
PEG Ratio
-7.12
Market Cap
₹3,128.55 Cr
P/B Ratio
3.39
EPS
18.66
Dividend Yield
0.23
Sector
Pharmaceuticals
ROE
12.39
based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 1 analysts offering long term price targets for Aarti Drugs Ltd. An average target of ₹465
Source: S&P Global Market Intelligence
Aarti Drugs Ltd price forecast by 1 analysts
Upside of36.64%
High
₹465
Target
₹465.00
Low
₹465
Aarti Drugs Ltd target price ₹465, a slight upside of 36.64% compared to current price of ₹340.3. According to 1 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Aarti Drugs Ltd revenue growth forecast
Expected growth rate Q1, FY2027:20.45%
Forecast
Actual
Including amortisation and stock based compensations
Aarti Drugs Ltd EPS growth forecast
EPS estimate Q1, FY2027:52.82%
Forecast
Actual
Source: S&P Global Market Intelligence
Aarti Drugs Warned by SEBI for Insider Trading - 07 Mar, 2025
Aarti Drugs Cleared by US FDA for Exports - 14 Feb, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
Mutual Funds have increased holdings from 6.25% to 7.78% in Dec 2024 quarter
Profit Spike
Netprofit is up for the last 3 quarters, 33.24 Cr → 37.05 Cr (in ₹), with an average increase of 5.3% per quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 70.5% return, outperforming this stock by 89.2%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 154.3%
Retail Holding Down
Retail Investor have decreased holdings from 34.02% to 33.57% in Dec 2024 quarter
Price Dip
In the last 3 years, AARTIDRUGS stock has moved down by -17.3%
Promoter Holding Down
Promoters have decreased holdings from 55.64% to 55.38% in Dec 2024 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 2.50% to 2.28% in Dec 2024 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 599.81 Cr → 568.5 Cr (in ₹), with an average decrease of 5.2% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 55.38% | ||
Foreign Institutions | 2.28% | ||
Mutual Funds | 7.78% | 24.40 | |
Retail Investors | 33.57% | ||
Others | 0.99% |
Aarti Drugs Ltd in the last 5 years
Lowest (8.29x)
March 31, 2020
Today (20.43x)
March 28, 2025
Industry (53.18x)
March 28, 2025
Highest (57.24x)
August 24, 2020
Aarti Drugs Ltd’s net profit jumped 1.04% since last year same period to ₹37.05Cr in the Q3 2024-2025. On a quarterly growth basis, Aarti Drugs Ltd has generated 5.83% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending December 2024, Aarti Drugs Ltd has declared dividend of ₹1 - translating a dividend yield of 0.29%.
Read More about DividendsBearish
Neutral
Bullish
Aarti Drugs Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹3,128.55 Cr | 35.84% | 0.64 | ₹171 Cr | ₹2,528 Cr | |
BUY | ₹29,300.43 Cr | 221.22% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
BUY | ₹14,271.69 Cr | 68.11% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
NA | ₹4,800.00 Cr | 13.52% | 0.79 | -₹388 Cr | ₹75 Cr | |
BUY | ₹14,234.50 Cr | 42.27% | 0.68 | ₹218 Cr | ₹1,296 Cr |
Organisation | Aarti Drugs Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Aarti Drugs Ltd share price today stands at ₹340.3, Open: ₹353, Previous Close: ₹353.1, High: ₹360, Low: ₹338.2, 52 Week High: ₹635, 52 Week Low: ₹330.05.
Today's traded volume of Aarti Drugs Ltd(AARTIDRUGS) is 2.65L.
Today's market capitalisation of Aarti Drugs Ltd(AARTIDRUGS) is ₹3128.55Cr.
Aarti Drugs Ltd (AARTIDRUGS) share price is ₹340.3. It is down -46.41% from its 52 Week High price of ₹635
Aarti Drugs Ltd (AARTIDRUGS) share price is ₹340.3. It is up 3.11% from its 52 Week Low price of ₹330.05